UK’s NICE Says ‘Light Touch’ HTA Evaluation Will Support Innovation
The UK’s health technology assessment body recognizes that its traditional product evaluation processes are too slow for innovative medtech products. Its new “conditional recommendation” pathway aims to fix this.
You may also be interested in...
Five digital mental health apps for children with low mood and anxiety are set to receive interim reimbursement via the UK’s early value assessment (EVA) pilot in a bid to tackle staff shortages and long waiting times for current interventions.
NICE, the body that produces health technology assessment guidance for England and Wales, has earlier this month introduced updates to its evidence standards guidance for developers of digital technologies based on artificial intelligence (AI) and on adaptive algorithms.
NICE’s recently launched early value assessment (EVA) pilot has hit a milestone this month, with AliveCor’s KardiaMobile 6L the first product to be given the go-ahead for NHS use in England under the scheme.